| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 151.836 | - | 112.938 | 167.413 | 204.160 | 31.157 | - |
| Total Income - EUR | - | - | - | 151.907 | - | 114.568 | 169.542 | 208.430 | 31.856 | - |
| Total Expenses - EUR | - | - | - | 136.501 | - | 111.132 | 116.153 | 191.658 | 30.800 | - |
| Gross Profit/Loss - EUR | - | - | - | 15.406 | - | 3.436 | 53.389 | 16.772 | 1.056 | - |
| Net Profit/Loss - EUR | - | - | - | 13.887 | - | 2.571 | 51.829 | 15.138 | 752 | - |
| Employees | - | - | - | 4 | - | 5 | 6 | 5 | 2 | - |
Check the financial reports for the company - Eleohromatitis Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 22.822 | - | 8.055 | 12.086 | 12.213 | 10.654 | - |
| Current Assets | - | - | - | 106.224 | - | 86.084 | 145.821 | 156.331 | 143.456 | - |
| Inventories | - | - | - | 316 | - | 4.649 | 2.520 | 4.589 | 1.693 | - |
| Receivables | - | - | - | 77.264 | - | 52.656 | 103.513 | 136.627 | 137.910 | - |
| Cash | - | - | - | 28.644 | - | 28.779 | 39.788 | 15.115 | 3.854 | - |
| Shareholders Funds | - | - | - | 125.624 | - | 90.629 | 140.448 | 156.022 | 149.584 | - |
| Social Capital | - | - | - | 43 | - | 41 | 40 | 41 | 40 | - |
| Debts | - | - | - | 3.423 | - | 3.510 | 17.458 | 12.523 | 4.526 | - |
| Income in Advance | - | - | - | 0 | - | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4333 - 4333" | |||||||||
| CAEN Financial Year |
4333
|
|||||||||
Comments - Eleohromatitis Srl